Astria Biosciences develops diagnostic and therapeutic solutions specifically targeting cerebrovascular disease. The company is creating a blood-based diagnostic test designed to detect and risk-stratify cerebral aneurysms. Furthermore, they are advancing molecular-based therapies aimed at combating this complex neurological condition.
Funding
$100K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for detecting and monitoring cerebral aneurysms often involve invasive procedures or expensive imaging techniques, posing risks and accessibility challenges for widespread screening and timely intervention. The lack of a simple, non-invasive diagnostic tool hinders early detection and risk stratification of these potentially life-threatening cerebrovascular conditions.
Solution
Astria Biosciences is developing a blood-based diagnostic test designed to detect the presence and monitor the progression of cerebral aneurysms. This non-surgical approach aims to provide a less invasive and more accessible alternative to traditional diagnostic methods. By leveraging advances in molecular biology and high-throughput analysis, Astria Biosciences seeks to transform the detection and management of cerebrovascular diseases, enabling earlier intervention and improved patient outcomes. The test is intended to identify individuals at risk and track disease progression, facilitating proactive clinical decision-making.
Target Audience
The primary target audience includes physicians, neurologists, and healthcare providers involved in the diagnosis and management of cerebrovascular diseases, as well as individuals at risk of developing cerebral aneurysms.
Features
- Whole blood-based assay for detecting cerebral aneurysms
- Non-invasive alternative to traditional neurosurgical diagnostics
- Designed for early detection and risk stratification
- Potential for monitoring disease progression over time
- Utilizes molecular biology and high-throughput analysis techniques